Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Martin

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Journal of Clinical Pharmacology|February 1, 1997
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitusD E Martin, G S DeCherney, B E Ilson, et al.
The Journal of Urology|June 1, 1989
Cardiovascular evaluation before circulatory arrest for removal of vena caval extension of renal carcinomaJ A Belis, W E Pae, T J Rohner, et al.
Clinical Pharmacology and Therapeutics|November 14, 1997
Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteersD J Kazierad, D E Martin, R A Blum, et al.
The Annals of Pharmacotherapy|April 9, 1998
Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteersD M Tenero, D E Martin, B E Ilson, et al.
Journal of the American Mosquito Control Association|October 18, 2007
Characterization of truck-mounted atomization equipment typically used in vector controlW C Hoffmann, T W Walker, D E Martin, et al.
Pharmaceutical Research|May 1, 1996
Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patientsD R Brocks, M I Freed, D E Martin, et al.
American Journal of Clinical Oncology|April 16, 1998
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trialJ Nemunaitis, D E Martin, D L Willis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2003
PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processingF Li, R Goila-Gaur, K Salzwedel, et al.
Oncogene|January 24, 2017
The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinomaC Hermanns, V Hampl, K Holzer, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Journal of Clinical Pharmacology|February 1, 1997
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitusD E Martin, G S DeCherney, B E Ilson, et al.
The Journal of Urology|June 1, 1989
Cardiovascular evaluation before circulatory arrest for removal of vena caval extension of renal carcinomaJ A Belis, W E Pae, T J Rohner, et al.
Clinical Pharmacology and Therapeutics|November 14, 1997
Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteersD J Kazierad, D E Martin, R A Blum, et al.
The Annals of Pharmacotherapy|April 9, 1998
Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteersD M Tenero, D E Martin, B E Ilson, et al.
Journal of the American Mosquito Control Association|October 18, 2007
Characterization of truck-mounted atomization equipment typically used in vector controlW C Hoffmann, T W Walker, D E Martin, et al.
Pharmaceutical Research|May 1, 1996
Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patientsD R Brocks, M I Freed, D E Martin, et al.
American Journal of Clinical Oncology|April 16, 1998
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trialJ Nemunaitis, D E Martin, D L Willis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2003
PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processingF Li, R Goila-Gaur, K Salzwedel, et al.
Oncogene|January 24, 2017
The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinomaC Hermanns, V Hampl, K Holzer, et al.
Pageof 11